Related Experiment Videos
Day-to-day management of asthma
1Department of Pediatrics, University of Iowa Hospitals, Iowa City.
Insights
Effective asthma management in children involves addressing airway obstruction and inflammation with appropriate medications and environmental controls. Tailoring treatment to the child's specific asthma pattern ensures optimal symptom control and reduced morbidity.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
Background:
- Asthma is a significant cause of childhood illness and death, despite advances in understanding its mechanisms and treatments.
- Effective asthma management requires addressing both airway obstruction (bronchial smooth muscle spasm) and inflammation (mucosal edema, mucous secretions).
Purpose of the Study:
- To outline current therapeutic strategies for pediatric asthma, encompassing pharmacologic and non-pharmacologic approaches.
- To emphasize the importance of individualized treatment based on asthma classification and triggers.
Main Methods:
- Review of pharmacologic options including bronchodilators, mediator inhibitors, and anti-inflammatory corticosteroids.
- Consideration of non-pharmacologic interventions such as environmental control and immunotherapy (allergenic extract injections).
Main Results:
- Treatment strategies differentiate between acute symptom reversal and long-term maintenance therapy.
- Environmental manipulation and immunotherapy are valuable adjuncts for specific patient subgroups.
- Appropriate healthcare delivery is crucial for successful asthma treatment outcomes.
Conclusions:
- Successful pediatric asthma management relies on a comprehensive approach considering pathophysiology, clinical patterns, and available therapeutic modalities.
- Tailored interventions, including medication, environmental adjustments, and immunotherapy, can significantly reduce asthma-related morbidity in children.
Abstract:
Asthma remains a major cause of morbidity and an occasional cause of mortality in children despite greatly increased knowledge of its pathophysiology and newer improved medications. Management of asthma requires consideration of the two components of airway obstruction, spasm of bronchial smooth muscle and inflammation resulting in mucosal edema and mucous secretions. The pharmacologic alternatives include medications that relax bronchial smooth muscle, prevent the release of mediators that induce bronchospasm and inflammation and anti-inflammatory corticosteroids that can reverse or prevent the inflammatory component of asthma. Therapeutic decisions in asthma also require consideration of the clinical pattern of disease which can be classified as intermittent, seasonal allergic or chronic. Therapeutic strategies for the use of pharmacologic agents include intervention measures for reversal of acute symptoms and maintenance measures to prevent symptoms. While all patients need available intervention measures to reverse acute symptoms when present, only those patients with prolonged periods of symptomatology, i.e. seasonal allergic or chronic, require pharmacologic agent for maintenance therapy. When evaluation identifies environmental factors as clinically important precipitants of asthma, appropriate environmental manipulation offers a potentially useful nonpharmacologic approach to therapy. The use of injections of allergenic extracts in selected patients with appropriate inhalant allergen sensitivity offers an immunologic approach for decreasing symptoms in patients with a predominant inhalant allergic component to their disease. Success in the treatment of asthma requires careful consideration of health care delivery. Available measures, when appropriately delivered to the patients when needed, have been convincingly demonstrated to greatly decrease morbidity.